The Effect of Smoking on Allogeneic Transplant Outcomes

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 10, 2009, Pages 1277-1287

  Marks, David I ^a   Ballen, Karen ^b   Logan, Brent R ^c   Wang, Zhiwei ^c   Sobocinski, Kathleen A ^c   Bacigalupo, Andrea ^d   Burns, Linda J ^e   Gupta, Vikas ^f   Ho, Vincent ^g   McCarthy, Philip L ^h   Ringdén, Olle ⁱ   Schouten, Harry C ^j   Seftel, Matthew ^k   Rizzo, J Douglas ^c  

^a UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h ROSWELL PARK CANCER INSTITUTE   (United States)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^k CANCERCARE MANITOBA   (Canada)

more..

Author keywords

Chronic myelogenous leukemia; Dose effect; Hematopoietic cell transplantation; Outcomes; Smoking effect

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYUREA; IMATINIB; IMMUNOSUPPRESSIVE AGENT; INTERFERON; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGRAFT; ARTICLE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; LEUKEMIA RELAPSE; LIVING DONOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PROGNOSIS; SIBLING; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SIBLINGS; SMOKING; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 69749091932     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.06.005     Document Type: Article

References (21)

1. Hansen J.A., Gooley T.A., Martin P.J., et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338 (1998) 962-968
2. Marks D.I., Cullis J.O., Ward K.N., et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 119 (1993) 207-214
3. Savani B.N., Montero A., Wu C., et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 223-230
4. Ho V.T., Weller E., Lee S.J., Alyea E.P., Antin J.H., and Soiffer R.J. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7 (2001) 223-229
5. Tichelli A., Bhatia S., and Socie G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol 142 (2008) 11-26
6. Lowe T., Bhatia S., and Somlo G. Second malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 13 (2007) 1121-1134
7. Office of Population Censuses and Surveys. General Household Survey 1978: Cigarette Smoking. OPCS monitor. Reference GHS 79/2 (1978)
8. Jha P., Peto R., Zatonski W., Boreham J., Jarvis M.J., and Lopez A.D. Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet 368 (2006) 367-370
9. McKee S.A., Harrison E.L., O'Malley S.S., et al. Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry 66 (2009) 185-190
10. Gratwohl A., Hermans J., Goldman J.M., et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 352 (1998) 1087-1092
11. Klein J.P., Rizzo J.D., Zhang M.J., and Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant 28 (2001) 909-915
12. Rigotti N.A. Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 346 (2002) 506-512
13. Ekbom A., Brandt L., Granath F., Lofdahl C.G., and Egesten A. Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD. Lung 186 (2008) 167-172
14. Robbins C.S., Franco F., Mouded M., Cernadas M., and Shapiro S.D. Cigarette smoke exposure impairs dendritic cell maturation and T cell proliferation in thoracic lymph nodes of mice. J Immunol 180 (2008) 6623-6628
15. Becklake M.R., Ghezzo H., and Ernst P. Childhood predictors of smoking in adolescence: a follow-up study of Montreal schoolchildren. CMAJ 173 (2005) 377-379
16. Chang G., Orav E.J., McNamara T., Tong M.Y., and Antin J.H. Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer 101 (2004) 782-789
17. Chang G., Orav E.J., Tong M.Y., and Antin J.H. Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics 45 (2004) 378-385
18. Clark J.G., Schwartz D.A., Flournoy N., Sullivan K.M., Crawford S.W., and Thomas E.D. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 107 (1987) 648-656
19. Socie G., Mary J.Y., Esperou H., et al. Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol 113 (2001) 194-201
20. Lund M.B., Brinch L., Kongerud J., and Boe J. Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide. Eur Respir J 23 (2004) 901-905
21. Marmot M. Smoking and inequalities. Lancet 368 (2006) 341-342